EYPT

#1999
EyePoint, Inc. - Common Stock
13.5 8 USD
+0.59%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
13.58
13.58
Range Annuel
0.12
19.01
Changement quotidien
+0.59%
Changement Mensuel
+4.38%
Evolution sur 6 mois
-7.37%
Changement Annuel
+13.17%
Clôture Précédente
13.5 0
Open
13.5 8
Low
13.5 8
High
13.5 8
Volume
145
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 1.14 B
  • Employee 214
  • Founded 2000
  • CEO N/A
  • Website www.eyepoint.bio
  • Headquarter Delaware, United States
  • FIGI BBG000F90JX5
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.76
ratio cours/chiffre d'affaires
0.04

EyePoint, Inc. - Common Stock

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

Nouvelles